Antipsychotics: mechanisms underlying clinical response and side-effects and novel treatment approaches based on pathophysiology

SJ Kaar, S Natesan, R Mccutcheon, OD Howes - Neuropharmacology, 2020 - Elsevier
Antipsychotic drugs are central to the treatment of schizophrenia and other psychotic
disorders but are ineffective for some patients and associated with side-effects and …

Schizophrenia: from neurochemistry to circuits, symptoms and treatments

OD Howes, BR Bukala, K Beck - Nature Reviews Neurology, 2024 - nature.com
Schizophrenia is a leading cause of global disability. Current pharmacotherapy for the
disease predominantly uses one mechanism—dopamine D2 receptor blockade—but often …

Dopamine and glutamate in schizophrenia: biology, symptoms and treatment

RA McCutcheon, JH Krystal, OD Howes - World Psychiatry, 2020 - Wiley Online Library
Glutamate and dopamine systems play distinct roles in terms of neuronal signalling, yet both
have been proposed to contribute significantly to the pathophysiology of schizophrenia. In …

Economics and mental health: the current scenario

M Knapp, G Wong - World Psychiatry, 2020 - Wiley Online Library
Economics and mental health are intertwined. Apart from the accumulating evidence of the
huge economic impacts of mental ill‐health, and the growing recognition of the effects that …

SEP-363856, a novel psychotropic agent with a unique, non-D2 receptor mechanism of action

N Dedic, PG Jones, SC Hopkins, R Lew, L Shao… - … of Pharmacology and …, 2019 - ASPET
For the past 50 years, the clinical efficacy of antipsychotic medications has relied on
blockade of dopamine D2 receptors. Drug development of non-D2 compounds, seeking to …

A test of the transdiagnostic dopamine hypothesis of psychosis using positron emission tomographic imaging in bipolar affective disorder and schizophrenia

S Jauhar, MM Nour, M Veronese, M Rogdaki… - JAMA …, 2017 - jamanetwork.com
Importance The dopamine hypothesis suggests that dopamine abnormalities underlie
psychosis, irrespective of diagnosis, implicating dopamine dysregulation in bipolar affective …

Determinants of treatment response in first-episode psychosis: an 18F-DOPA PET study

S Jauhar, M Veronese, MM Nour, M Rogdaki… - Molecular …, 2019 - nature.com
Psychotic illnesses show variable responses to treatment. Determining the neurobiology
underlying this is important for precision medicine and the development of better treatments …

The relationship between cortical glutamate and striatal dopamine in first-episode psychosis: a cross-sectional multimodal PET and magnetic resonance spectroscopy …

S Jauhar, R McCutcheon, F Borgan… - The Lancet …, 2018 - thelancet.com
Background The pathophysiology of psychosis is incompletely understood. Disruption in
cortical glutamatergic signalling causing aberrant striatal dopamine synthesis capacity is a …

A potential biomarker for treatment stratification in psychosis: evaluation of an [18F] FDOPA PET imaging approach

M Veronese, B Santangelo, S Jauhar… - …, 2021 - nature.com
Abstract [18F] FDOPA PET imaging has shown dopaminergic function indexed as K icer
differs between antipsychotic treatment responders and non-responders. However, the …

Striatal dopamine and reward prediction error signaling in unmedicated schizophrenia patients

T Katthagen, J Kaminski, A Heinz… - Schizophrenia …, 2020 - academic.oup.com
Increased striatal dopamine synthesis capacity has consistently been reported in patients
with schizophrenia. However, the mechanism translating this into behavior and symptoms …